Quick Summary

Cranberry (Vaccinium macrocarpon) is widely studied for potential benefits in urinary tract infection (UTI) prevention, metabolic and cardiovascular health, and oral health. Clinical evidence suggests cranberry products may reduce the risk of recurrent UTIs in certain populations, with variable results on inflammation and cardiometabolic markers. Evidence on efficacy for treatment of active infections or other conditions is limited or inconclusive. Safety data indicates cranberry is generally well tolerated with minor gastrointestinal side effects. More high-quality, long-term randomized controlled trials are needed to confirm efficacy and standardize clinical recommendations.

What Is It

Cranberry is a small, evergreen shrub native to North America, bearing bright red berries. The cranberry fruit and its extracts are commonly used as dietary supplements and in food products for their flavor and potential health benefits.

Traditional Uses

Traditionally, cranberry has been used to support urinary tract health and to help reduce the occurrence of urinary tract infections (UTIs). It has also been employed for general antioxidant properties and oral hygiene purposes.

Active Compounds

  • Polyphenols, including proanthocyanidins (PACs)
  • Anthocyanins
  • Flavonoids
  • Organic acids

Potential Benefits with Evidence Levels

Urinary Tract Infection Prevention

Cranberry products may reduce the risk of recurrent urinary tract infections, especially in women with recurrent UTI, children, and people susceptible after interventions.

Evidence Level: Moderate (multiple systematic reviews and meta-analyses of randomized controlled trials including up to 8857 participants)

Urinary Tract Infection Treatment

There is no good quality clinical trial evidence supporting cranberry for treatment of active urinary tract infections.

Evidence Level: Insufficient (no RCTs meeting criteria for efficacy in treatment)

Cardiometabolic Health

Cranberry consumption showed potential beneficial effects on some lipid parameters (total cholesterol/HDL cholesterol ratio) and insulin resistance markers (HOMA-IR), but no consistent effects on blood pressure or inflammatory markers.

Evidence Level: Low to moderate (systematic reviews and meta-analyses of human RCTs with mixed findings)

Oral Health and Cariogenic Bacteria

Herbal extracts including cranberry exhibit antimicrobial activity against cariogenic bacteria, and may contribute to gingival health and dental care, though evidence specific to cranberry is limited.

Evidence Level: Low (mostly in vitro and preliminary clinical studies)

Antioxidant and Anti-inflammatory Effects

Cranberry contains polyphenols with antioxidant potential; however, systematic reviews indicate inconsistent effects on inflammatory biomarkers such as C-reactive protein (CRP) and interleukin-6 (IL-6) in humans.

Evidence Level: Low to moderate

Side Effects

Cranberry products are generally well tolerated. Mild gastrointestinal intolerance, including nausea and diarrhea, has been reported especially with cranberry juice. Overall adverse event rates in clinical trials are comparable to placebo. Switching from juice to capsule forms may reduce gastrointestinal side effects.

Drug Interactions

No specific evidence from the supplied data was found regarding drug interactions with cranberry. However, general caution is advised due to potential interactions with anticoagulants and other medications as known from broader literature.

Who Should Avoid It

Individuals with a known allergy to cranberry should avoid its use. There is insufficient evidence for the safety of cranberry use in patients with severe kidney disease or other critical illnesses.

Evidence Limitations

  • Significant heterogeneity among clinical trials in cranberry type, dose, duration, and participant populations limits generalizability.
  • Many studies have unclear or high risk of bias.
  • Most clinical trials are short term; long-term safety and efficacy data are scarce.
  • Limited clinical trial evidence supports cranberry in treatment (versus prevention) of UTIs.
  • Inconsistencies and low certainty in evidence regarding inflammation and cardiometabolic effects.
  • Lack of standardized outcome measures and dosing regimens.
  • Need for large, double-blind, placebo-controlled randomized controlled trials especially in pregnant women and specific at-risk populations.

References

Last Reviewed

June 2024

Disclaimer

The information provided here is for educational purposes only and is not intended as medical advice. Cranberry and related products should not replace professional medical diagnosis or treatment. Always consult with a healthcare professional before starting any new supplement, especially if you have underlying health conditions or are taking medications.